This document outlines a presidential action plan for infectious endocarditis in children. It begins with definitions of infective endocarditis and discusses the epidemiology, pathogenesis, clinical features, diagnosis, treatment and prevention. Key points include that infective endocarditis is less common in children than adults but is increasing in those with cardiac surgery or conditions. Common causes are streptococcal and staphylococcal species. Clinical features may include fever, heart murmur and embolic phenomena. Echocardiography is important for diagnosis but blood cultures are also needed under the modified Duke criteria. Surgery may be indicated for complications such as heart failure or abscesses.
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
1. PRESIDENTIAL ACTION PLAN 2018
Ref:
INFECTIVE ENDOCARDITIS IN CHILDREN
MURTAZA KAMAL
5TH JAN, 2019
2. PRESIDENTIAL ACTION PLAN 2018
Ref:
Definition
Epidemiology
Pathogenesis/ Pathology/ Microbiology
Clinical features
Diagnosis & Diagnostic criteria
Treatment
Preventive methods
Scope of the talk…
3. PRESIDENTIAL ACTION PLAN 2018
Ref:
Microbial infection of endocardial (endothelial) surface of heart
Native/ prosthetic valves: Most frequently involved
Can involve septal defects, mural endocardium, intravascular
foreign devices, intracardiac patches, surgically constructed
shunts, IV catheters
Disease classification on basis of etiologic agent involved:
Low virulence organisms (Alpha hemolytic streptococcai,
enterococci, CONS): Prolonged subacute form of illness
Virulent organisms (Staph aureus, strept pneumoniae, beta
hemolytic streptococci): Acute clinical course
Definition
Gewitz M, Taubert KA. IE and prevention. In: Heart disease in infant, children andadolescents. 9th ed. Philadelphia:
Wolter Kluwer; 2016: 1441-1453
4. PRESIDENTIAL ACTION PLAN 2018
Ref:
Less often in children than in adults
1: 1280 (0.78/1000) paediatric admissions/ year
Overall frequency among children and a shift towards those with
previous cardiac surgery: Increased Improved survival among
children who are at risk of IE, such as those with CHD (with/
without surgery) and hospitalised neonates
CHD: Predominant underlying condition in developed world (MC:
VSD, TOF, aortic valve abnormalities)
Post operative IE: Long term risk after correction of complex CHD,
esp those with residual defects/ surgical shunts/ prosthetic
materials
Epidemiology
Van Hare GF, Ben-Shachar G, Liebman J, Boxerbaum B, RiemenschneiderTA. Infective endocarditis in infants and children during the past 10 years:
a decade of change. Am Heart J. 1984;107:1235–1240.
Pasquali SK, He X, Mohamad Z, McCrindle BW, Newburger JW, Li JS,Shah SS. Trends in endocarditis hospitalizations at US children’s hospitals:
impact of the 2007 American Heart Association antibiotic prophylaxisguidelines. Am Heart J 2012;143:894–899.
5. PRESIDENTIAL ACTION PLAN 2018
Ref:
RHD: Before 1970s, 30-50% children with IE Decreased now as
prevalence of RHD decreased in developed countries
8-10% of pediatric cases: IE develops without structural heart
disease: Central indwelling venous catheters Mostly aortic or
mitral valves are involved by staph aureus
Neonates: 7.3% cases: Right sided heart structures involved
Factors associated with IE in adults like IV drug abuse and
degenerative heart diseases: Not common predisposing factor
Epidemiology Cont…
Baltimore RS. Infective endocarditis. In: Jenson HB, Baltimore RS,eds. Pediatric Infectious Diseases: Principles and Practice. 2nd ed.
Philadelphia, PA: Saunders; 2002.
Stull TL, LiPuma JJ. Endocarditis in children. In: Kaye D, ed. InfectiveEndocarditis. 2nd ed. New York, NY: Raven Press; 1992:313–327
Stockheim JA, Chadwick EG, Kessler S, Amer M, Abdel-Haq N, DajaniAS, Shulman ST. Are the Duke criteria superior to the Beth Israel criteria
for the diagnosis of infective endocarditis in children? Clin Infect Dis.1998;27:1451–1456.
6. PRESIDENTIAL ACTION PLAN 2018
Ref:
2 important factors:
Damaged area of endothelium and
Bacteremia (even transient)
Structural abnormalities of heart/ great arteries+ significant
pressure gradient/ turbulence Endothelial damage Thrombus
formation with deposition of sterile clumps of platelet and fibrin
Nonbacterial thrombus Nidus for bacteria to adhere and form
infected vegetation
Bacteremia from dental procedures
Bacteremia with activities such as chewing/ brushing teeth
Chewing with diseased teeth or gums frequent cause of bacteremia
Good dental hygiene very important in prevention
Pathogenesis
7. PRESIDENTIAL ACTION PLAN 2018
Ref:
Vegetation:
Usually on low-pressure side of defect
Either around defect or on opposite surface of defect where
endothelial damage is established by jet effect of defect
Vegetations found in PA in PDA or systemic-to-PA shunts
On atrial surface of mitral valve in MR
On ventricular surface of aortic valve and mitral chordae in
AR
On superior surface of aortic valve or at site of a jet lesion in
aorta in AS
Pathology
8. PRESIDENTIAL ACTION PLAN 2018
Ref:
Streptococcus viridans, Enterococci and Staphylococcus
aureus: 50%- 60%
Fungi+ HACEK organisms (Haemophilus, Actinobacillus,
Cardiobacterium, Eikenella, and Kingella spp.): 17% to 30%
α-Hemolytic streptococci (S. viridans): Dental procedures/
carious teeth/ periodontal disease
Enterococci: After GU/ GI surgery/ instrumentation
Staphyloccocci: Postoperative endocarditis
S. aureus: IV drug abusers
Fungal endocarditis (poor prognosis): Sick neonates/ long-
term antibiotic or steroid therapy/ after open heart surgery
Fungal endocarditis: Associated with very large friable
vegetations; emboli from these vegetations frequently
produce serious complications
Microbes: The Agent
9. PRESIDENTIAL ACTION PLAN 2018
Ref:
S. aureus/ CONS: Indwelling vascular catheters/ prosthetic material/
prosthetic valves
S. aureus/ CONS/ Candida: MCC among newborn infants
Culture-negative endocarditis: 5-7%
Patient has clinical or echo evidence of endocarditis but
persistently negative blood culture results
MCC: Current or recent antibiotic therapy or infection caused
by a fastidious organism that grows poorly in vitro
Fungal endocarditis: A rare cause of culture-negative
endocarditis
Diagnosis can be made only by removal of vegetation (during
surgery) sometimes
Microbes: The Agent…
10. PRESIDENTIAL ACTION PLAN 2018
Ref:
Most patients have history of underlying heart defect
Some patients with bicuspid aortic valve may not have been diagnosed
with defect before
History of a recent dental procedure/ tonsillectomy / toothache (from
dental or gingival disease)
Endocarditis: Rare in infancy; at this age, usually follows open heart
surgery
Onset usually insidious with prolonged low-grade fever and somatic
complaints, fatigue, weakness, loss of appetite, pallor, arthralgia,
myalgias, weight loss, and diaphoresis
Clinical Features: History
11. PRESIDENTIAL ACTION PLAN 2018
Ref:
Heart murmur: Universal (100%)
Appearance of new heart murmur/ Increase in intensity of an
existing murmur
Fever: 80%–90%; 101° and 103°F
Splenomegaly: 70%
Skin manifestations: 50%; Either secondary to microembolization or as
an immunologic phenomenon:
Petechiae on skin/ mucous membranes/ conjunctivae
Osler’s nodes: Tender, pea-sized red nodes at ends of fingers/
toes
Janeway’s lesions: Small, painless, hemorrhagic areas on palms/
soles
Splinter hemorrhages: Linear hemorrhagic streaks beneath
nails
Clinical Features: Examination
13. PRESIDENTIAL ACTION PLAN 2018
Ref:
Clinical Features: Examination
Embolic/ immunologic phenomena in other organs: 50%
Pulmonary emboli: VSD, PDA or a systemic-to-PA shunt
Seizures and hemiparesis: Embolization to CNS-20%
Hematuria and renal failure
Roth’s spots- 5%:
Oval, retinal hemorrhages
with pale centers located
near optic disc
From AAP. Red Book Online visual library, 2006
14. PRESIDENTIAL ACTION PLAN 2018
Ref:
Clinical Features: Examination
Clubbing of fingers in absence of cyanosis rarely in chronic cases
Heart failure as a complication of infection
Neonate:
Nonspecific and may be indistinguishable from septicemia or CHF
from other causes
Embolic phenomena (osteomyelitis, meningitis) common
Neurologic signs and symptoms (seizures,hemiparesis, apnea)
15. PRESIDENTIAL ACTION PLAN 2018
Ref:
Positive blood cultures:
90% in absence of previous antimicrobial therapy
50-60% pretreatment with antibiotics
CBC:
Anemia: 80%
Leukocytosis with a shift to the left
Patients with polycythemia preceding onset of IE may
have normal hemoglobin
ESR: Increased unless there is polycythemia.
Microscopic hematuria: 30%
Lab Studies
16. PRESIDENTIAL ACTION PLAN 2018
Ref:
Main modality for detection
Site of infection, extent of valvular damage and cardiac function
Baseline evaluation of ventricular function and cardiac chamber
dimension important for comparison later
Color Doppler: Sensitive modality for detection of valvular
regurgitation
Role of ECHOCARDIOGRAPHY
Vegetations on the aortic valve
17. PRESIDENTIAL ACTION PLAN 2018
Ref:
Echocardiographic findings included as major criteria in
modified Duke criteria:
Oscillating intracardiac mass on valves or supporting
structures, in path of regurgitation jets, or on
implanted material
Abscesses
New partial dehiscence of prosthetic valve
New valvular regurgitation
Role of ECHOCARDIOGRAPHY
18. PRESIDENTIAL ACTION PLAN 2018
Ref:
TEE superior to TTE:
Vegetations on prosthetic valves
Detecting complications of LV outflow tract endocarditis
Detecting aortic root abscess and involvement of sinus of
Valsalva
Absence of vegetations on echo: Does not rule out IE
False-negative: Vegetations are small or have embolized and they
may miss initial perivalvular abscess
Repeat examinations indicated if suspicion exists without
diagnosis of IE or worrisome clinical course during early
treatment of IE
Role of ECHOCARDIOGRAPHY
19. PRESIDENTIAL ACTION PLAN 2018
Ref:
False-positive:
An echogenic mass may represent a sterile
thrombus, sterile prosthetic material, normal
anatomic variation, an abnormal uninfected valve
(previous scarring, severe myxomatous changes),
or improper gain of echo machine
Echocardiographic evidence of vegetation may persist for
months or years after bacteriologic cure
Role of ECHOCARDIOGRAPHY
21. PRESIDENTIAL ACTION PLAN 2018
Ref:
Definite IE :
Pathological evidence of IE:
Demonstration of microorganism by culture
Histology in a vegetation or from an embolic sites or an
intracardiac abscess or histologic evidence of active
endocarditis demonstrated in vegetation or
intracardiac abscess
Fulfillment of clinical criteria:
2 major criteria
1 major+ 3 minor criteria
5 minor criteria
DIAGNOSIS: Modified Dukes Criteria
22. PRESIDENTIAL ACTION PLAN 2018
Ref:
Possible IE: When one of the following is present:
1 major+ 1 minor criterion
3 minor criteria
Rejected IE:
An alternative diagnosis is established
Clinical manifestations of IE have resolved within
4 days of antibiotic therapy
No pathological evidence is found on direct
examination of vegetation obtained from surgery
or autopsy after antibiotic therapy for < 4 days
Criteria for possible IE are not met
DIAGNOSIS: Modified Dukes Criteria
23. PRESIDENTIAL ACTION PLAN 2018
Ref:
1. Blood culture positive for IE:
Typical microorganisms consistent with IE from 2 separate
blood cultures: Viridans streptococci, Streptococcus bovis,
HACEK group, Staphylococcus aureus; or community-
acquired enterococci in absence of a primary focus or
Microorganisms consistent with IE from persistently positive
blood cultures defined as: at least 2 positive cultures of
blood samples drawn >12 h apart or all of 3 or a majority of 4
or more separate cultures of blood (with first and last sample
drawn at least 1 h apart)
Single positive blood culture for Coxiella burnetii or anti–
phase 1 IgG antibody titer >1:800
Modified Dukes: Major Criteria
24. PRESIDENTIAL ACTION PLAN 2018
Ref:
2. Evidence of endocardial involvement
Echocardiogram positive for IE (TEE recommended for
patients with prosthetic valves, rated at least “possible IE”
by clinical criteria, or complicated IE [paravalvular abscess];
TTE as first test in other patients) defined as follows:
Oscillating intracardiac mass on valve or supporting
structures, in path of regurgitant jets, or on implanted
material in absence of an alternative anatomic explanation
Abscess
New partial dehiscence of prosthetic valve
New valvular regurgitation (worsening or changing or
preexisting murmur not sufficient)
Modified Dukes: Major Criteria
25. PRESIDENTIAL ACTION PLAN 2018
Ref:
Predisposition, predisposing heart condition, or IDU
Fever, temperature >38°C
Vascular phenomena: Major arterial emboli, septic pulmonary
infarcts, mycotic aneurysm, intracranial hemorrhage, conjunctival
hemorrhages and Janeway’s lesions
Immunologic phenomena: Glomerulonephritis, Osler’s nodes,
Roth’s spots and rheumatoid factor
Microbiologic evidence: Positive blood culture but does not meet a
major criterion or serologic evidence of active infection with
organism consistent with IE
Modified Dukes: Minor Criteria
26. PRESIDENTIAL ACTION PLAN 2018
Ref:
Blood cultures: Indicated for all patients with fever of unexplained
origin and a pathologic heart murmur, a history of heart disease or
previous endocarditis
Usually 3 blood cultures are drawn by separate venipunctures over 24
hours unless patient is very ill
90% of cases, causative agent is recovered from 1st 2 cultures
If no growth by 2nd day of incubation, 2 more may be obtained
No value in obtaining >5 blood cultures over 2 days unless patient
received prior antibiotic therapy
Not necessary to obtain cultures at any particular phase of fever cycle
Adequate volume: 1-3 mL infants; 5-7 mL older children
Aerobic incubation alone sufficient
Management
27. PRESIDENTIAL ACTION PLAN 2018
Ref:
Recommended that consultation from local infectious disease
specialist be obtained when IE suspected/confirmed: Antibiotics of
choice continually changing, and there may be special situation
pertaining to local area
Initial empirical therapy:
Usual initial regimen: Antistaphylococcal semisynthetic
penicillin (nafcillin,oxacillin or methicillin)+ aminoglycoside
(gentamicin)
Covers against S. viridans, S. aureus, and gram-negative
organisms
Vancomycin:
Methicillin-resistant S. aureus suspected
Penicillin-allergic patients
Management
28. PRESIDENTIAL ACTION PLAN 2018
Ref:
Depends on organism isolated+ results of antibiotic sensitivity test
Streptococcal IE:
Native cardiac valve IE caused by highly sensitive S. viridans:
IV penicillin (or ceftriaxone OD) X 4 weeks
Alternatively penicillin, ampicillin or ceftriaxone+
gentamicin for 2 weeks
IE caused by penicillin-resistant streptococci:
4 weeks of penicillin, ampicillin or ceftriaxone+
gentamicin for 2 weeks
Final antibiotic selection
29. PRESIDENTIAL ACTION PLAN 2018
Ref:
Staphylococcal endocarditis:
Drug of choice native valve IE by methicillin-susceptible
staphylococci: Semisynthetic β-lactamase–resistant penicillins
(nafcillin, oxacillin or methicillin) X minimum of 6 weeks (±
gentamicin X 3–5 days)
Methicillin-resistant native valve IE: Vancomycin X 6 weeks (±
gentamicin X 3–5 days)
Enterococcus:
IV penicillin/ ampicillin+ gentamicin X 4 to 6 weeks
Allergic to penicillin: Vancomycin +gentamicin x 6 weeks
HACEK organisms:
Ceftriaxone/ another 3rd generation cephalosporin alone or
ampicillin+ gentamicin x 4 weeks
Final antibiotic selection
30. PRESIDENTIAL ACTION PLAN 2018
Ref:
IE by other gram-negative bacteria (E coli, Pseudomonas
aeruginosa, or Serratia marcescens):
Piperacillin/ ceftazidime together+ gentamicin X 6 weeks
Amphotericin B: Most effective agent for most fungal infections
Culture-negative endocarditis:
Treatment directed against staphylococci, streptococci and
HACEK organisms using ceftriaxone+ gentamicin
When staphylococcal IE suspected, nafcillin should be
added to the above therapy
Final antibiotic selection
31. PRESIDENTIAL ACTION PLAN 2018
Ref:
Should be treated for 6 weeks based on organism isolated
and results of sensitivity test
Operative intervention may be necessary before antibiotic
therapy is completed if clinical situation warrants:
Progressive CHF
Significant malfunction of prosthetic valves
Persistently positive blood cultures after 2 weeks of
therapy
Bacteriologic relapse after an appropriate course of
therapy
Prosthetic valve Endocarditis
32. PRESIDENTIAL ACTION PLAN 2018
Ref:
Overall recovery rate: 80%- 85%
90% or better: S. viridans and enterococci
50%: Staphylococcus organisms
Fungal endocarditis: Very poor outcome
Prognosis
33. PRESIDENTIAL ACTION PLAN 2018
Ref:
Prevention
Emphasis should be on maintaining good oral hygiene and
eradicating dental disease to decrease frequency of
bacteremia from routine daily activities
Recommended for tonsillectomy and adenoidectomy only in
high-risk patients
Prophylaxis no longer recommended:
For routine bronchoscopy
For GI or genitourinary procedures, such as diagnostic
esophagogastroduodenoscopy or colonoscopy
34. PRESIDENTIAL ACTION PLAN 2018
Ref:
Patients with prosthetic cardiac valve/ material used for cardiac valve
repair
Patients with previous IE
Patients with CHD:
Unrepaired cyanotic CHD, including palliative shunts/ conduits
Completely repaired CHD with prosthetic material/ device,
whether placed by surgery or catheter intervention, during 1st
6 months after procedure
Repaired CHD with residual defects at site or adjacent to site
of a prosthetic patch/ device (which inhibits
endothelialization)
Cardiac transplantation recipients with valve regurgitation caused by
a structurally abnormal valve
Cardiac conditions for which prophylaxis
With dental procedures is recommended
35. PRESIDENTIAL ACTION PLAN 2018
Ref:
Dental procedures:
Involving manipulation of gingival tissue of periapical region
or perforation of oral mucosa
Respiratory tract procedures:
Procedures that involve incision/ biopsy of respiratory mucosa
Not recommended for bronchoscopy
GI or GU procedures:
No prophylaxis for diagnostic esophagogastroduodenoscopy/
colonoscopy
Reasonable in patients with infected GI/GU tract
Skin, skin structure or musculoskeletal tissue:
Surgical procedures that involve infected skin, skin structure,
or musculoskeletal tissue
Procedures for which IE
Prophylaxis is recommended
36. PRESIDENTIAL ACTION PLAN 2018
Ref:
Prophylactic regimens for
Dental procedures
Park. Pediatric cardiology for practitioners; 6th edition
37. PRESIDENTIAL ACTION PLAN 2018
Ref:
Special Considerations
Patients already receiving antibiotics:
Rheumatic fever prophylaxis: Use other antibiotics, such as
clindamycin, azithromycin or clarithromycin
Delay a procedure until 10 days after completion of antibiotic
Patients who undergo cardiac surgery:
Careful preoperative dental evaluation so that required dental
treatment may be completed whenever possible before surgery
Prophylaxis at time of surgery: Primarily against staphylococci
Prophylaxis should be initiated immediately before surgery,
repeated during prolonged procedures to maintain serum
concentrations intraoperatively, and continued for no more
than 48 hours postoperatively
38. PRESIDENTIAL ACTION PLAN 2018
Ref:
IE in children is not uncommon
Common in children with CHD
Neonates: Poor outcome
Blood culture + ECHO has important role in diagnosis
Treatment adherence necessary
Prognosis not bad if treated properly
Knowledge of conditions requiring prophylaxis and drugs for it
necessary
Take Home Message